Biolegend, 583714, Cell-Vive™ GMP Recombinant Human VEGF-165 (carrier-free)

Name: Cell-Vive™ GMP Recombinant Human VEGF-165 (carrier-free)
Brand: Biolegend
SKU: 583714

25microg

Catalog Number: 583714

Pricing

Send an RFQ.

View RFQ List

Category

Amino Acids

Description

VEGF (known also as VEGFA) was initially identified in conditioned medium from bovine pituitary follicular cells. VEGFA belongs to the VEGF family, which has the following members: VEGF-A, VEGF-B, VEGF-C (VEGF-2), VEGF-D, and PlGF (placental growth factor). In addition, viral VEGF homologs (collectively called VEGF-E) and snake venom VEGFs, such as T.f. (Trimeresurus flavoviridis) and svVEGF (called VEGF-F), have been described. VEGFA is alternatively spliced to generate variants with different numbers of amino acids, such as VEGFA121, VEGFA145, VEGFA165, and VEGFA189. VEGFA165 is predominant and responsible for VEGFA biological potency. While VEGF121 is freely diffusible and does not bind to neuropilins (NRPs) or heparan sulphate (HS), VEGF165 and VEGF189 bind to both, resulting in retention on the cell surface or in the extracellular matrix. NRP1 lacks a typical kinase domain and acts as a co-receptor, and in response to VEGF165, NRP1 couples with VEGF-Rs to signal in endothelial cells. In addition, it has been suggested that bone marrow cells that are recruited to Ewing’s tumors are differentiated into vascular smooth muscle cells, and VEGF165 is responsible for this differentiation. VEGFA is highly expressed in most of the solid tumors generated in breast, lung, renal, colorectal, and liver tissues. VEGFA has strong vascular permeability activity, and significantly contributes to the formation of ascites tumors. VEGFA can act as a direct proinflammatory mediator during the pathogenesis of rheumatoid arthritis (RA), and protect rheumatoid synoviocytes from apoptosis, which contributes to synovial hyperplasia. VEGFA is expressed in synovial macrophages and synovial fibroblasts in RA patients. Also, VEGFA is associated to age-related macular degeneration (AMD). AMD is due to neovascularization that originates from endothelial cells in the choroid that grow into neurosensory retina as choroidal neovascularization (CNV). BioLegend Cell-Vive™ GMP Recombinant proteins are manufactured and tested in accordance with USP Chapter 1043, Ancillary Materials for Cell, Gene and Tissue-Engineered Products and Ph. Eur. Chapter 5.2.12 in a dedicated GMP facility compliant with ISO 13485:2016. Specifications and processes include:

Specifications

General

Source	Human VEGF-165, amino acids Ala27-Arg191 (Accession# AAM03108) was expressed in 293E cells.
Molecular Mass	The 165 amino acid recombinant protein has a predicted molecular mass of approximately 19 kD. The DTT-reduced protein migrates at approximately 20-28 kD and non-reduced protein migrates at 50 kD by SDS-PAGE. The N-terminal amino acid is Alanine.
N-terminalSequence Analysis	Ala-Pro-Met-Ala-Glu-Gly-Gly-Gly-Gln-Asn
Purity	≥ 95%, as determined by Coomassie stained SDS-PAGE
Formulation	0.1 µm filtered protein solution is in 5 mM citric acid, 5 mM Na2HPO4, 0.15 M NaCl pH 4.0.
Endotoxin Level	Less than or equal to 0.1 EU per μg protein as determined by the LAL method
Residual Host Cell Protein Content	≤ 0.500 ng/μg by ELISA
Concentration	500 µg/mL
Storage & Handling	Unopened vial can be stored between 2°C and 8°C for up to 2 weeks, at -20°C for up to six months, or at -70°C or colder until the expiration date. For maximum results, quick spin vial prior to opening. The protein can be aliquoted and stored at -20°C or colder. Stock solutions can also be prepared at 50 - 100 µg/mL in appropriate sterile buffer, carrier protein such as 0.2 - 1% endotoxin-free BSA or HSA can be added when preparing the stock solution. Aliquots can be stored between 2°C and 8°C for up to one week or stored at -20°C or colder for up to 3 months. Avoid repeated freeze/thaw cycles.

Ordering

Notice

Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:

[email protected]

Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.

Biolegend, 583714, Cell-Vive™ GMP Recombinant Human VEGF-165 (carrier-free)

Send an RFQ.

General

Notice

More from Biolegend.

Zombie Aqua™ Fixable Viability Kit

FITC anti-human CD3 Antibody

FITC anti-human CD3 Antibody

PE/Cyanine7 anti-human CD154

More from Biolegend.

Zombie Aqua™ Fixable Viability Kit

FITC anti-human CD3 Antibody

FITC anti-human CD3 Antibody

PE/Cyanine7 anti-human CD154